Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment
January 16, 2025 08:30 ET
|
Femasys Inc.
FemaSeed® patent application provides additional coverage for Femasys’ therapeutic option for women seeking infertility solution ATLANTA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq:...
U.S. Breast Cancer Screening & Diagnostic Market Analysis and Forecast 2024-2030 - Multi-Modality Imaging Revolutionizes Breast Cancer Diagnostics, Boosting Detection Accuracy
January 16, 2025 04:04 ET
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "U.S. Breast Cancer Screening and Diagnostic Market: Analysis and Forecast, 2024-2030" report has been added to ResearchAndMarkets.com's offering.The...
Australia Non-Invasive Prenatal Testing (NIPT) Market Research 2024-2033: Opportunities in the Expansion of NIPT Accessibility and Coverage, & Expanding Applications of NIPT Products
January 14, 2025 07:27 ET
|
Research and Markets
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Australia Non-Invasive Prenatal Testing (NIPT) Market: Focus on Technology, Method, Application, and End User - Forecast, 2024-2033" report has been...
Breast Cancer Brachytherapy Market Sees $1.88 Billion Opportunity by 2035: Elekta, Varian Medical Systems, and Isoray Dominate the Competitive Landscape
January 13, 2025 06:47 ET
|
Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer Brachytherapy Market by Technology, Product, End User, and Region" report has been added to ResearchAndMarkets.com's offering. This...
Uterine Leiomyoma Competitive Landscape Research Report 2024: R&D Activities Stall with 12 Molecules in the Pipeline, Phase III Holds Only Three Drugs Whereas Phase II Holds Only Two Drugs
January 10, 2025 07:27 ET
|
Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Uterine Leiomyoma: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven overview of...
Dysmenorrhea Competitive Landscape Report 2024: R&D Efforts are Limited, with Only Four Drug Candidates Currently in the Pipeline with None in Phase II or Phase III Trials
January 10, 2025 07:18 ET
|
Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Dysmenorrhea: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven overview of the...
In-Vitro Fertilization (IVF) Devices and Consumables Market Report 2024: Preimplantation Genetic Testing, Cryopreservation, Advanced Infertility Treatments, and Enhanced Genetic Screening Fuel Growth
January 08, 2025 08:56 ET
|
Research and Markets
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "In-Vitro Fertilization (IVF) Devices and Consumables Market Report 2024" report has been added to ResearchAndMarkets.com's offering.This In Vitro...
Non-Invasive Prenatal Testing (NIPT) Market Report 2025: Rising Demand for Early and Accurate Fetal Screening Spurs Growth in Non-Invasive Prenatal Testing Market
January 07, 2025 11:47 ET
|
Research and Markets
Dublin, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The "Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Minus Coffee Launches Beanless Instant Oat Milk Latte to Fuel Your Day Without the Coffee Crash
January 07, 2025 11:03 ET
|
Minus Coffee
San Francisco, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Minus Coffee today announced Minus Instant Vanilla Oat Milk Latte, an instant coffee designed to fuel your day without the typical crash that comes...
Europe Non-Invasive Prenatal Testing (NIPT) Market Analysis and Forecast to 2033: Increasing Focus on Non-Invasive Pre-Implantation Genetic Testing (niPGT)
December 30, 2024 07:50 ET
|
Research and Markets
Dublin, Dec. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Platform, End User, Application, and Country - Analysis and Forecast, 2023-2033"...